INTERSPECIES DIFFERENCES IN CANCER SUSCEPTIBILITY AND TOXICITY*

REFERENCES

• Oesch F., Diener B. Cell systems for use in studies on the relationship between foreign compound metabolism and toxicity. Pharmacol. Toxicol. 1995; 76: 325–327
   PubMedGoogle Scholar
• Steinberg P., Biefang K., Kiulies S., Fischer T., Platt K. L., Oesch F., Boüttger T., Hengstler J. G., Drug metabolizing capacity of cryopreserved human, rat and mouse liver parenchymal cells held in suspension, unpublished
   Google Scholar
• Diener B., Traiser M., Arand M., Leissner J., Witzsch U., Hohenfellner R., Fandrich F., Vogel I., Utesch D., Oesch F. Xenobiotic metabolizing enzyme activities in isolated and cryopreserved human liver parenchymal cells. Toxic. In vitro 1994; 8: 1161–1166
   PubMed Web of Science ®Google Scholar
• Caldwell J. Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolism. Toxicol. Lett. 1992; 64/65: 651–659
   Web of Science ®Google Scholar
• Adamson R. H., Thorgeirsson U. P., Sugimura T. Extrapolation of heterocyclic amine carcinogenesis data from rodents and nonhuman primates to humans. Arch. Toxicol. 1996; 18(Suppl.)303–318
   Google Scholar
• Buonarati M., Felton J. S. Activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites. Carcinogenesis 1990; 11: 1133–1138
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Kaderlik K. R., Butler M. A., Lin D.-X., Mulder G. J., Minchin R. F., Friesen M. D., Bartsch H., Nago M., Esumi H., Sugimura T., Lang N. P. Metabolic activation of PhIP in rats, dogs, and humans. Proceedings of the 232rd Princess Takamatsu Cancer Research Symposium. Princeton Science Publishers, Princeton, NJ 1995
   Google Scholar
• Snyderwine E. G., Turesky R. J., Turteltaub K. W., Davis C. D., Sadrieh N., Schut H. A., Nago M., Sugimura T., Thorgeirsson U. P., Adamson R. H., Thorgeirsson S. S. Metabolism of food-derived heterocyclic amines in nonhuman primates. Mutat. Res. 1997; 376: 203–210
   PubMed Web of Science ®Google Scholar
• Davis C. D., Adamson R. H., Snyderwine E. G. Studies on the mutagenic activation of heterocyclic amines by cynomolgus monkey, rat and human microsomes show that cynomolgus monkeys have a low capacity to N-oxidize the quinoxaline-type heterocyclic amines. Cancer Lett. 1993; 73: 95–104
   PubMed Web of Science ®Google Scholar
• Sesardic D., Cole K. J., Edwards R. J., Davies D. S., Thomas P. E., Levin W., Boobis A. R. The inducibility and catalytic activity of cytochromes P450c (P4501A1) and P450d (P4501A2) in rat tissues. Biochem. Pharmacol. 1990; 39: 499–506
   PubMed Web of Science ®Google Scholar
• Sesardic D., Boobis A. R., Edwards R. J., Davies D. S. A form of cytochrome P450 in man, orthologous to form d in the rat catalyzes the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 1989; 26: 363–372
   Web of Science ®Google Scholar
• Sadrieh N., Snyderwine E. G. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis 1995; 16: 1549–1455
   PubMed Web of Science ®Google Scholar
• Edwards R. J., Murray B. P., Murray S., Schultz T., Neubert D., Gant T. W., Thorgeirsson S. S., Boobis A. R., Davies D. S. Contribution of CYP 1A1 and CYP 1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis 1994; 15: 829–836
   PubMed Web of Science ®Google Scholar
• Boobis A. R., Gooderham N. J., Edwards R. J., Murray S., Lynch A. M., Yadollahi-Farsani M., Davies D. S. Enzymic and interindividual differences in the human metabolism of heterocyclic amines. Arch. Toxicol. 1996; 18(Suppl.)286–302
   Google Scholar
• Turesky R. J., Aeschbacher H. U., Wurzner H. P., Skipper P. L., Tannenbaum S. R. Major routes of metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the rat. Carcinogenesis 1988; 9: 1043–1048
   PubMed Web of Science ®Google Scholar
• Alexander J., Wallin H., Home J. A., Becher G. 4-(2-Amino-1-methylimidazo[4,5-b]pyrid-6-yl)phenyl sulfate—a major metabolite of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Carcinogenesis 1989; 10: 1543–1547
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Abu-Zeid M., Manabe S., Toyama S., Kato R. Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P450. Carcinogenesis 1988; 9: 105–109
   PubMed Web of Science ®Google Scholar
• Ohmori S., Horie T., Guengerich F. P., Kiuchi M., Kitada M. Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys. Arch. Biochem. Biophys. 1993; 305: 405–413
   PubMed Web of Science ®Google Scholar
• Aoyama T., Gelboin H. V., Gonzalez F. J. Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450. Cancer Res. 1990; 50: 2060–2063
   PubMed Web of Science ®Google Scholar
• Lin D.-X., Lang N. P., Kadlubar F. F. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Disp. 1995; 23: 518–524
   PubMed Web of Science ®Google Scholar
• Wallin H., Milkalsen A., Guengerich F. P., Ingelman-Sundberg M., Solberg K. E., Rossland O. J., Alexander J. Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. Carcinogenesis 1990; 11: 489–492
   PubMed Web of Science ®Google Scholar
• Hengstler J. G., Arand M., Herrero M. E., Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility. Genes and Environment in Cancer, H. M. Rabes. Karger, Bonn 1998
   Google Scholar
• Roberts-Thomson I. C., Ryan P., Khoo K. K., Hart W. J., McMichael A. J., Butler R. N. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996; 347: 1372–1374
   PubMed Web of Science ®Google Scholar
• Schiffmann M. H., Felton J. S. Fried foods and the risk of colon cancer. Am. J. Epidemiol. 1990; 131: 376–378
   PubMed Web of Science ®Google Scholar
• de Verdier M. Gerhardsson, Hagman U., Peters R. K., Steineck G., Overvik E. Meat cooking methods and colorectal cancer: A case-referent study in Stockholm. Int. J. Cancer 1991; 49: 520–525
   PubMed Web of Science ®Google Scholar
• Lang N. P., Butler M. A., Massengill J., Lawson M., Stotts R. C., Hauer-Jensen M., Kadlubar F. F. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev. 1994; 3: 675–682
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Willett W. C. Intake of fat, meat and fiber in relation to risk of colon cancer in men. Cancer Res. 1994; 54: 2390–2397
   PubMed Web of Science ®Google Scholar
• Oesch F., Hengstler J. G., Fuchs J. Cigarette smoking protects mononuclear blood cells of carcinogen exposed workers from additional work-exposure induced DNA single strand breaks. Mutat. Res. 1994; 321: 175–185
   PubMed Web of Science ®Google Scholar
• Morel F., Fardel O., Meyer D. J., Langouet S., Gilmore K. S., Meunier B., Tu C. P., Kensler T. W., Ketterer B., Guillouzo A. Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones. Cancer Res. 1993; 53: 231–234
   PubMed Web of Science ®Google Scholar
• Schrenk D., Stuven T., Goh G., Viebahn R., Bock K. W. Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures. Carcinogenesis 1995; 16: 943–946
   PubMed Web of Science ®Google Scholar
• Sinha R., Rothman N., Brown E. D., Mark S. D., Hoover R. N., Caporaso N. E., Levander O. A., Knize M. G., Lang N. P., Kadlubar F. F. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P450 1A2 activity in humans. Cancer Res. 1994; 54: 6154–6159
   PubMed Web of Science ®Google Scholar
• Steinberg P., Jennings G. S., Schlemper B., Oesch F. Molecular mechanisms underlying the liver cell-type specific toxicity of Aflatoxin B1. Control Mechanisms of Carcinogenesis, J. Hengstler, F. Oesch. Druckerei Thieme, Mainz 1996
   Google Scholar
• Wild C. P. G., Jansen A. M., Cova L., Montesano R. Molecular dosimetry of aflatoxin exposure: Contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ. Health Perspect. 1993; 99: 115–122
   PubMed Web of Science ®Google Scholar
• Busby W. F., Wogan G. N. Aflatoxins. Chemical Carcinogens, Volume 2, C. Searle. American Chemical Society Monograph 182, American Chemical Society, Washington, DC 1984; 945–1136
   Google Scholar
• Ueno I. E., Friedman L., Stone C. L. Species difference in the binding of aflatoxin B1 to hepatic macromolecules. Toxicol. Appl. Pharmacol. 1980; 52: 177–180
   PubMed Web of Science ®Google Scholar
• Garner R. C., Wright C. M. Binding of [14C]aflatoxin B1 to cellular macromolecules in the rat and hamster. Chem. Biol. Interact. 1975; 11: 123–131
   Web of Science ®Google Scholar
• Lotlikar P. D., Jhee E. C., Insetta S. M., Clearfield M. S. Modulation of microsome-mediated aflatoxin B1 binding to exogenous and endogenous DNA by cytosolic glutathione S-transferase in rat liver. Carcinogenesis 1984; 5: 269–276
   PubMed Web of Science ®Google Scholar
• Lutz W. K., Jaggi W., Luthy J., Sagelsdorff P., Schlatter C. In vivo covalent binding of aflatoxin B1 and aflatoxin M1 to liver DNA of rat, mouse and pig. Chem. Biol. Interact. 1980; 32: 249–250
   PubMed Web of Science ®Google Scholar
• Croy R. G., Wogan G. N. Quantitative comparison of covalent aflatoxin–DNA adducts formed in rat and mouse livers and kidneys. J. Natl. Cancer Inst. 1981; 66: 761–768
   PubMed Web of Science ®Google Scholar
• Cole K. E., Jones T. W., Lipsky M. M., Trump B. F., Hsu I. C. In vitro binding of aflatoxin B1 and 2-acetylaminofluorene to rat, mouse and human hepatocyte DNA: The relationship of DNA binding to carcinogenicity. Carcinogenesis 1988; 9: 711–716
   PubMed Web of Science ®Google Scholar
• Anwar W. A., Khalil M. M., Wild C. P. Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1. Mutat. Res. 1994; 322: 61–67
   PubMed Web of Science ®Google Scholar
• Steinmetz K. L., Green C. E., Bakke J. P., Spak D. K., Mirsalis J. C. Induction of unscheduled DNA synthesis in primary cultures of rat, mouse, hamster, and human hepatocytes. Mutat. Res. 1988; 206: 91–102
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Metabolic control of carcinogens. Control Mechanisms of Carcinogens, J. Hengstler, F. Oesch. Druckerei Thieme, Mainz 1996
   Google Scholar
• Ramsdell H. S., Eaton D. L. Species susceptibility to aflatoxin B1 carcinogenesis: Comparative kinetics of microsomal biotransformation. Cancer Res. 1990; 50: 615–620
   PubMed Web of Science ®Google Scholar
• Wilson A. S., Williams D. P., Davis C. D., Tingle M. D., Park B. K. Bioactivation and inactivation of aflatoxin B1 by human, mouse and rat liver preparations: Effect on SCE in human mononuclear leucocytes. Mutat. Res. 1997; 373: 257–264
   PubMed Web of Science ®Google Scholar
• Gallagher E. P., Wienkers L. C., Stapleton P. L., Kunze K. L., Eaton D. L. Role of human microsomal and human complementary DNA-expressed cytochrome P450 1A2 and cytochrome P450 3A4 in the bioactivation of aflatoxin B1. Cancer Res. 1994; 54: 101–108
   PubMed Web of Science ®Google Scholar
• Buetler T. M., Bammler T. K., Hayes J. D., Eaton D. L. Oltipraz-mediated changes in aflatoxin B1 biotransformation in rat liver: Implications for human chemointervention. Cancer Res. 1996; 56: 2306–2313
   PubMed Web of Science ®Google Scholar
• Slone D. H., Gallagher E. P., Ramsdell H. S., Rettie A. E., Stapleton P. L., Berlad L. G., Eaton D. L. Human variability in hepatic glutathione S-transferase-mediated conjugation of aflatoxin B1-epoxide and other chemicals. Pharmacogenetics 1995; 5: 224–233
   PubMedGoogle Scholar
• Buetler T. M., Slone D., Eaton D. L. Comparison of the aflatoxin B1–8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat. Biochem. Biophys. Res. Commun. 1992; 188: 597–603
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Judah D. J., McLellan L. I., Kerr L. A., Peacock S. D., Neal G. E. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem. J. 1991; 279: 385–398
   PubMed Web of Science ®Google Scholar
• Quinn B. A., Crane T. L., Kocal T. E., Best S. J., Cameron R. G., Rushmore T. H., Faber E., Hayes M. A. Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1. Toxicol. Appl. Pharmacol. 1990; 105: 351–363
   PubMed Web of Science ®Google Scholar
• Eaton D. L., Gallagher E. P. Mechanism of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 1994; 34: 135–172
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Motycka L. Effect of sex differences on the in vitro and in vivo metabolism of aflatoxin B1 by the rat. Cancer Res. 1976; 36: 4663–4671
   PubMed Web of Science ®Google Scholar
• Shank R. C., Bhamarapravati N., Gordon J. E., Wogan G. N. Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations in Thailand. Food Cosmet. Toxicol. 1972; 10: 171–179
   PubMedGoogle Scholar
• Peers F. G., Linsell C. A. Dietary aflatoxins and human primary liver cancer. Ann. Nutr. Aliment 1997; 31: 1005–1018
   Google Scholar
• Rasmussen B. B., Brosen K. Determination of urinary metabolites of caffeine for the assessment of cytochrome P450 1A2, xanthine oxidase, and N-acetyltransferase activity in humans. Ther. Drug Monit. 1996; 18: 254–262
   PubMed Web of Science ®Google Scholar
• Horn E. P., Tucker M. A., Lambert G., Silverman D., Zametkin D., Sinha R., Hartge T., Landi M. T., Caporaso N. E. A study of gender-based cytochrome P4501A2 variability: A possible mechanism for the male excess of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 1995; 4: 529–533
   PubMed Web of Science ®Google Scholar
• Bolton M. G., Munoz A., Jacobson L. P., Groopman J. D., Maxuitenko Y. Y., Roebuck B. D., Kensler T. W. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res. 1993; 53: 3499–3504
   PubMed Web of Science ®Google Scholar
• Langouet S., Coles B., Morel F., Becquemont L., Beaune P., Guengerich F. P., Ketterer B., Guillouzo A. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res. 1995; 55: 5574–5579
   PubMed Web of Science ®Google Scholar
• Morel F., Langouet S., Maheo K., Guillouzo A. The use of primary hepatocyte cultures for the evaluation of chemoprotective agents. Cell Biol. Toxicol. 1997; 13: 323–329
   PubMed Web of Science ®Google Scholar
• Luch A., Platt K. L. Metabolism, DNA-interaction and mutagenesis: Fundamental events in carcinogenesis by polycyclic aromatic hydrocarbons. Control Mechanisms of Carcinogenesis, J. Hengstler, F. Oesch. Druckerei Thieme, Mainz 1996; 66–97
   Google Scholar
• Dao T. G.L. Carcinogenesis of mammary gland in rat. Progr. Exp. Tumor Res. 1964; 5: 157–216
   PubMed Web of Science ®Google Scholar
• Huggins C. B. Experimental Leukemia and Mammary Cancer. University of Chicago Press, Chicago 1979; 73–99
   Google Scholar
• Moore C. J., Eldridge S. R., Tricomi W. A., Gould M. N. Quantitation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene binding to nuclear macromolecules in human and rat mammary epithelial cells. Cancer Res. 1987; 47: 2609–2613
   PubMed Web of Science ®Google Scholar
• Moore C. J., Pruess-Schwartz D., Mauthe R. J., Gould M. N., Baird W. M. Interspecies differences in the major DNA adducts formed from benzo[a]pyrene but not 7,12-dimethylbenz[a]anthracene in rat and human mammary cell cultures. Cancer Res. 1987; 47: 4402–4406
   PubMed Web of Science ®Google Scholar
• Gould M. N., Grau D. R., Seidman L. A., Moore C. J. Interspecies comparison of human and rat mammary epithelial cell-mediated mutagenesis by polycyclic aromatic hydrocarbons. Cancer Res. 1986; 46: 4942–4945
   PubMed Web of Science ®Google Scholar
• DiGiovanni J., Romson J. R., Linville D., Juchau M. R. Covalent binding of polycyclic aromatic hydrocarbons to adenine correlates with tumorigenesis in mouse skin. Cancer Lett. 1979; 7: 39–53
   PubMed Web of Science ®Google Scholar
• Phillips D. H., Hewer A., Grover P. L. Aberrant activation of benzo- [a]pyrene in cultured rat mammary cells in vitro and following direct application in rat mammary glands in vivo. Cancer Res. 1985; 45: 4167–4174
   PubMed Web of Science ®Google Scholar
• Eldridge S. R., Gould M. N., Butterworth B. E. Genotoxicity of environmental agents in human mammary epithelial cells. Cancer Res. 1992; 52: 5617–5621
   PubMed Web of Science ®Google Scholar
• Li D., Wang M., Dhingra K., Hittelman W. N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res. 1996; 56: 287–293
   PubMed Web of Science ®Google Scholar
• Oesch F., Raphael D., Schwind H., Glatt H. R. Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites. Arch. Toxicol. 1977; 39: 97–108
   PubMed Web of Science ®Google Scholar
• Oesch F. Species differences in activating and inactivating enzymes related to in vitro mutagenicity mediated by tissue preparations from these species. Arch. Toxicol. 1980; 3(Suppl.)179–194
   Google Scholar
• Glatt H. R., Oesch F. Species differences in enzymes controlling reactive epoxides. Arch. Toxicol. 1987; 10(Suppl.)111–124
   Google Scholar
• Phillipson C. E., Ioannides C. Metabolic activation of polycyclic aromatic hydrocarbons to mutagens in the Ames test by various animal species including man. Mutat. Res. 1989; 211: 147–151
   PubMed Web of Science ®Google Scholar
• Roggenband R., Wolterbeek A. P. M., Rutten A. A. J. J. L., Baan R. A. Comparative 32P-postlabeling analysis of benzo[a]pyrene-DNA adducts in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes. Carcinogenesis 1993; 14: 1945–1950
   PubMed Web of Science ®Google Scholar
• Seidel A., Soballa V. J., Raab G., Frank H., Greim H., Grimmer G., Jacob J., Doehmer J. Regio- and stereoselectivity in the metabolism of benzo[c]phenanthrene mediated by genetically engineered V79 Chinese hamster cells expressing rat and human cytochromes P450. Environ. Toxicol. Pharmacol. 1998; 5: 179–196
   PubMed Web of Science ®Google Scholar
• McConnell E. E., Moore J. A., Haseman J. K., Harris M. W. The comparative toxicity of chlorinated dibenzo-p-dioxin in mice and guinea pigs. Toxicol. Appl. Pharmacol. 1978; 44: 335–356
   PubMed Web of Science ®Google Scholar
• Hankinson O., Bacsi S. G., Fukunaga B. N., Kozak K. R., McNulty S. E., Minehart E., Probst M. R., Reisz-Porszasz S., Sun W., Zhang J. Role of the aryl hydrocarbon receptor in carcinogenesis. Control Mechanisms of Carcinogenesis, J. Hengstler, F. Oesch. Druckerei Thieme, Mainz 1996
   Google Scholar
• Fernandez-Salguero P. G., Pineau T., Hilbert D. M., McPhail T., Lee S. S., Kimura S., Nebert D. W., Rudikoff S., Ward J. M., Gonzalez F. J. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995; 268: 722–726
   PubMed Web of Science ®Google Scholar
• Andreola F., Fernandez-Salguero P. M., Chiantore M. V., Petkovich M. P., Gonzalez F. J., DeLuca. L. M. Aryl hydrocarbon receptor knockout mice (AHR –/–) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 1997; 57: 2835–2838
   PubMed Web of Science ®Google Scholar
• Fernandez-Salguero P. M., Hilbert D. M., Rudikoff S., Ward J. M., Gonzalez F. J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 1996; 140: 173–179
   PubMed Web of Science ®Google Scholar
• Kozak K. R., Abbott B., Hankinson O. ARNT-deficient mice and placental differentiation. Dev. Biol. 1997; 191: 287–305
   Google Scholar
• Schwetz B., Norris J., Sparschu G., Rowe V., Gehring P., Emerson J., Gerbig C. Toxicology of chlorinated dibenzo-p-dioxins. Environ. Health Perspect. 1973; 5: 87–99
   PubMedGoogle Scholar
• Olson J. R., Holscher M. A., Neal R. A. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the golden Syrian hamster. Toxicol. Appl. Pharmacol. 1980; 55: 67–78
   PubMed Web of Science ®Google Scholar
• Peterson R. E., Theobald H. M., Kimmel G. L. Developmental and reproductive toxicity of dioxins and related compounds: Cross-species comparisons. Crit. Rev. Toxicol. 1993; 23: 283–335
   PubMed Web of Science ®Google Scholar
• Huff J. E., Salmon A. G., Hooper N. K., Zeise L. Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins. Cell. Biol. Toxicol. 1991; 7(1)67–74
   PubMed Web of Science ®Google Scholar
• Hays S. M., Aylward L. L., Karch N. J., Paustenbach D. J. The relative susceptibility of animals and humans to the carcinogenic hazard posed by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: An analysis using standard and internal measures of dose. Chemosphere 1997; 34: 1507–1522
   PubMed Web of Science ®Google Scholar
• Poland A., Palen D., Glover E. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 1994; 46: 915–921
   PubMed Web of Science ®Google Scholar
• Gielen J. E., Goujon F. M., Nebert D. W. Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo. J. Biol. Chem. 1972; 247: 1125–1137
   PubMed Web of Science ®Google Scholar
• Poland A., Glover E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Segregation of toxicity with the Ah locus. Mol. Pharmacol. 1980; 17: 86
   PubMed Web of Science ®Google Scholar
• Jones K. G., Sweeney G. D. Dependence of the porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness. Toxicol. Appl. Pharmacol. 1980; 53: 42
   PubMed Web of Science ®Google Scholar
• Vecchi A., Sironi M., Antonia M., Recchia C. M., Garattini S. Immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different susceptibility. Proc. Natl. Acad. Sci. USA 1983; 87: 6917
   Google Scholar
• Pohjanvirta R., Viluksela M., Tuomisto J. T., Unkila M., Karasinska J., Franc M. A., Holowenko M., Giannone J. V., Harper P. A., Tuomisto J., Okey A. B. Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains. Toxicol. Appl. Pharmacol. 1999; 155: 82–95
   PubMed Web of Science ®Google Scholar
• Tuomisto J. T., Viluksela M., Pohjanvirta R., Tuomisto J. The AH receptor and a novel gene determine acute toxic responses to TCDD: Segregation of the resistant alleles to different rat lines. Toxicol. Appl. Pharmacol. 1999; 155: 71–81
   PubMed Web of Science ®Google Scholar
• Nakai J. S., Winhall M. J., Bunce N. J. Comparative kinetic study of the binding between 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands with the hepatic Ah receptors from several rodent species. J. Biochem. Toxicol. 1997; 9: 199–209
   Google Scholar
• Bank P. A., Yao E. F., Phelps C. L., Harper P. A., Denison M. S. Species-specific binding of transformed Ah receptor to a dioxin responsive transcriptional enhancer. Eur. J. Biochem 1992; 228: 85–94
   Google Scholar
• Rozman K. A critical review on the mechanisms of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment. Derm. Beruf. Umwelt 1989; 37: 81–92
   PubMedGoogle Scholar
• Weber L. D.W., Lebofsky M., Stahl B. U., Gorski J. R., Muzi G., Rozman K. Reduced activities of key enzymes of gluconeogenesis as a possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology 1991; 66: 133
   PubMed Web of Science ®Google Scholar
• Unkila M., Ruotsalainen M., Pohjanvirta R., Viluksela M., MacDonald E., Tuomistro J., Rozman K., Tuomisto J. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tryptophan and glucose homeostasis in most TCDD-susceptible and the most TCDD-resistent species, guinea pigs and hamsters. Arch. Toxicol. 1995; 69: 677–683
   PubMed Web of Science ®Google Scholar
• Unkila M., Pohjanvirta R., MacDonald E., Tuomistro J. Characterization of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced brain serotonin metabolism in the rat. Eur. J. Pharmacol. 1994; 270: 157–166
   PubMed Web of Science ®Google Scholar
• Geyer H. J., Schramm K.-W., Scheunert I., Schughart K., Buters J., Wurst W., Greim H., Kluge R., Steinberg C. E. W., Kettrup A., Madhukar B., Olson J. R., Gallo M. A. Considerations on genetic and environmental factors that contribute to resistance or sensitivity of mammals including humans to toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Ecotoxicol, Environ. Safety 1997; 36: 213–230
   PubMed Web of Science ®Google Scholar
• Lawrence G. S., Gobas F. A. A pharmacokinetic analysis of interspecies extrapolation in dioxin risk assessment. Chemosphere 1997; 35: 427–452
   PubMed Web of Science ®Google Scholar
• Wroblewski V. J., Olson J. R. Hepatic metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat and guinea pig. Toxicol. Appl. Pharmacol. 1985; 81: 231–240
   PubMed Web of Science ®Google Scholar
• Kavlock R. J., Daston G. P., DeRosa C., Fenner-Crisp P., Gray L. E., Kaattar S., Lucier G., Luster M., Mac M. J., Miller R. Maczka, Moore J., Rolland R., Scott G., Sheehan D. M., Sinks T., Tilson H. A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 1996; 104(Suppl. 4)715–740
   PubMed Web of Science ®Google Scholar
• Safe S. H. Environmental and dietary estrogens and human health: Is there a problem?. Environ. Health Perspect. 1995; 103: 346–351
   PubMed Web of Science ®Google Scholar
• Guillette L. J., Gross T. S., Masson G. R., Matter J. M., Percival H. F., Woodward A. R. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ. Health Perspect. 1994; 102: 680–688
   PubMed Web of Science ®Google Scholar
• Kavlock R. J., Ankley G. T. A perspective on the risk assessment process for endocrine-disruptive effects on wildlife and human health. Risk Anal. 1996; 16: 731–739
   PubMed Web of Science ®Google Scholar
• Fent K. Ecotoxicology of organotin compounds. Crit. Rev. Toxicol. 1996; 26: 1–117
   PubMed Web of Science ®Google Scholar
• Jardine J. J., Van der Kraak G. J., Munkittrick K. R. Capture and confinement stress in white sucker exposed to bleached kraft pulp mill effluent. Ecotoxicol. Environ. Safety 1996; 33: 287–298
   PubMed Web of Science ®Google Scholar
• MacLatchy D. L., Van Der Kraak G. J. The phytoestrogen beta-sitosterol alters the reproductive endocrine status of goldfish. Toxicol. Appl. Pharmacol. 1995; 134: 305–312
   PubMed Web of Science ®Google Scholar
• Gilbertson M., Kubiak T., Ludwig J., Fox G. Great Lakes embryo mortality, edema, and deformities syndrome in colonial fish-eating birds: Similarity to chic-edema disease. J. Toxicol. Environ. Health 1991; 33: 455–520
   PubMed Web of Science ®Google Scholar
• Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina. Association of Maternal Diethylstilbestrol Therapy with Tumor Appearance in Young Women. New Engl. J. Med. 1971; 284: 878–881
   PubMed Web of Science ®Google Scholar
• Colton T., Greenberg R., Noller K., Resseguie L., Van Bennekom C., Heeren T., Zhang Y. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA 1993; 269: 2096–2100
   PubMed Web of Science ®Google Scholar
• Schantz S. L. Developmental neurotoxicity of PCBs in humans: What do we know and where do we go from here?. Neurotoxicol. Teratol. 1996; 18: 217–227
   PubMed Web of Science ®Google Scholar
• Lai T. J., Guo Y. L., Yu M. L., Ko H. C., Hsu C. C. Cognitive development in Yucheng children. Chemosphere 1994; 29: 2405–2411
   PubMed Web of Science ®Google Scholar
• Morse D. C., Plug A., Wesseling W., Van den Berg K. J., Brouwer A. Persistent alterations in regional brain glial fibrillary acidic protein and synaptophysin levels following pre- and postnatal polychlorinated biphenyl exposure. Toxicol. Appl. Pharmacol. 1996; 139: 252–261
   PubMed Web of Science ®Google Scholar
• Brouwer A., Morse D. C., Lans M. C., Schuur A. G., Murk A. J., Klasson-Wehler E., Bergman A., Visser T. J. Interactions of persistent environmental organohalogens with the thyroid hormone system: Mechanisms and possible consequences for animal and human health. Toxicol. Ind. Health 1998; 14: 59–84
   PubMed Web of Science ®Google Scholar
• Schuur A. G., Legger F. F., Van Meeteren M. E., Moonen M. J., Van Leeuwen-Bol I., Bergman A., Visser T. J., Brouwer A. In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem. Res. Toxicol. 1998; 11: 1075–1081
   PubMed Web of Science ®Google Scholar
• De Boer J., Wester P. G., Klamer H. J., Lewis W. E., Boon J. P. Do flame retardants threaten ocean life?. Nature 1998; 394: 28–29
   PubMed Web of Science ®Google Scholar
• Harrison P. T., Holmes P., Humfrey C. D. Reproductive health in humans and wildlife: Are adverse trends associated with environmental chemical exposure?. Sci. Total Environ. 1997; 205: 97–106
   PubMed Web of Science ®Google Scholar
• German Research Council (DFG) Hormonal active substances in diet, G. Eisenbrand. Wiley–VCH, Weinheim 1998; 1–23
   Google Scholar
• Cassidy A., Bingham S., Setchell K. Biological effects of isoflavones in young women: Importance of the chemical composition of soyabean products. Br. J. Nutr. 1995; 74: 587–601
   PubMed Web of Science ®Google Scholar
• Cassidy A., Bingham S., Setchell K. D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr. 1995; 60: 333–340
   Web of Science ®Google Scholar
• Obermeyer W. R., Musser S. M., Betz J. M., Casey R. E., Pohland A. E., Page S. W. Chemical studies of phytoestrogens and related compounds in dietary supplements: Flax and chaparral. Proc. Soc. Exp. Biol. Med. 1995; 208: 6–12
   PubMed Web of Science ®Google Scholar
• Guillette L. J., Guillette E. A. Environmental contaminants and reproductive abnormalities in wildlife: Implications for public health?. Toxicol. Ind. Health 1996; 12: 537–550
   PubMed Web of Science ®Google Scholar
• Arnold S. F., Vonier P. M., Collins B. M., Klotz B. M., Guillette L. J., McLachlan J. A. In vitro synergistic interaction of alligator and human estrogen receptors with combinations of environmental chemicals. Environ. Health Perspect. 1997; 105(Suppl. 3)615–618
   PubMedGoogle Scholar
• Vonier P. M., Crain D. A., McLachlan J. A., Guillette L. J., Arnold S. F. Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator. Environ. Health. Perspect. 1996; 104: 1318–1322
   PubMed Web of Science ®Google Scholar
• Bryan G. W., Gibbs P. E., Hummerstone L. G., Burt G. R. The decline of the gastropod Nucella lapillus around south-west England: Evidence for the effect of tributyltin from antifouling paints. J. Marine Biol. Assoc. UK 1986; 66: 611–640
   Web of Science ®Google Scholar
• Toppari J., Larsen J. C., Christiansen P., Giwercman A., Grandjean P., Guillette L. J., Jegou B., Jensen T. K., Jouannet T. K., Keiding N., Leffers H., McLachlan J. A., Meyer H., Muller H., De Meyts E. Rajpert, Scheike T., Sharpe R., Sumpter J., Skakkebaek N. E. Male reproductive health and environmental xenoestrogens. Environ. Health Perspect. 1996; 104(Suppl. 4)741–803
   PubMed Web of Science ®Google Scholar
• Harrison P. T., Holmes P. T., Humfrey P. T. Reproductive health in humans and wildlife: Are adverse trends associated with environmental chemical exposure?. Sci. Total Environ. 1997; 205: 97–106
   PubMed Web of Science ®Google Scholar
• Piferrer F., Donaldson E. M. Gonadal differentiation in coho salmon (Oncorhynchus kisutch) after a single treatment with bandrogen or estrogen at different stages during ontogenesis. Aquaculture 1989; 77: 251–262
   Web of Science ®Google Scholar
• Fisher B., Costantino J. P., Wickerham D. L., Redmond D. L., Kavanah D. L., Cronin W. M., Vogel V., Robidoux A., Dimitrov A., Atkins J., Daly J., Wieand J., Chiu J. Tan, Ford L., Wolmark L. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 1998; 90: 1371–1388
   PubMed Web of Science ®Google Scholar
• Jordan V. C., Robinson S. P. Species-specific pharmacology of anti estrogens: Role of metabolism. Fed. Proc. 1987; 46: 1870–1874
   PubMedGoogle Scholar
• Wogan G. N. Review of the toxicology of tamoxifen. Semin. Oncol 1997; 24: S1-87–S1-97
   Web of Science ®Google Scholar
• Tannenbaum S. R. Comparative metabolism of tamoxifen and DNA adduct formation and in vitro studies on genotoxicity. Semin. Oncol. 1997; 24(Suppl. I)S1-81–S1-86
   Google Scholar
• Coe J. E., Ishak K. G., Ward J. M., Ross M. J. Tamoxifen prevents induction of hepatic neoplasms by zeranol, and estrogenic food contaminant. Proc. Natl. Acad. Sci. USA 1992; 89: 1085–1089
   PubMed Web of Science ®Google Scholar
• Ramakrishna K. V., Fan P. W., Boyer C. S., Dalvie D., Bolton J. L. Oxo substituents markedly alter the phase II metabolism of alpha-hydroxybutenylbenzenes: Models probing the bioactivation mechanisms of tamoxifen. Chem. Res. Toxicol. 1997; 10: 887–894
   PubMed Web of Science ®Google Scholar
• Phillips D. H., Carmichael P. L., Hewer A., Cole K. J., Hardcastle I. R., Poon G. K., Keogh A., Strain A. J. Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: Comparisons between human, rat and mouse hepatocytes. Carcinogenesis 1996; 17: 89–94
   PubMed Web of Science ®Google Scholar
• Dasaradhi L., Shibutani S. Identification of tamoxifen adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen. Chem. Res. Toxicol. 1997; 10: 189–196
   PubMed Web of Science ®Google Scholar
• Randerath K., Moorthy B., Mabon N., Sriram P. Tamoxifen: Evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. Carcinogenesis 1994; 15: 2087–2094
   PubMed Web of Science ®Google Scholar
• Randerath K., Bi J., Mabon N., Sriram P., Moorthy B. Strong intensification of mouse hepatic tamoxifen DNA adduct formation by pretreatment with the sulfotransferase inhibitor and ubiquitous environmental pollutant pentachlorophenol. Carcinogenesis 1994; 15: 797–800
   PubMed Web of Science ®Google Scholar
• Mani C., Gelboin H. V., Park S. S., Pearce R., Parkinson A., Kupfer D. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Drug Metab. Disp. 1993; 21: 645–656
   PubMed Web of Science ®Google Scholar
• Lim C. K., Yuan Z.-X., Lamb J. H., White I. N., De Matteis F., Smith L. L. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis 1994; 15: 589–593
   PubMed Web of Science ®Google Scholar
• Martin E. K., Rich K. J., White I. N. H., Woods K. L., Powles T. J., Smith L. L. 32P-Postlabelled DNA adducts in liver obtained from women treated with tamoxifen. Carcinogenesis 1995; 16: 1651–1654
   PubMed Web of Science ®Google Scholar
• Pathak D. N., Pongraez K., Bodell W. J. Uterine peroxidase activation of tamoxifen metabolites to form DNA adducts: Comparison with the adducts formed in the uterus of Sprague–Dawley rats treated with tamoxifen. Proc. Am. Assoc. Cancer. Res. 1996; 37: 119
   Google Scholar
• Carmichael P. L., Ugwumadu A. H. N., Neven P., et al. Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res. 1996; 56: 1475–1479
   PubMed Web of Science ®Google Scholar
• Eberhard D. C. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin. Mol. Pharmacol. 1991; 40: 859–867
   PubMed Web of Science ®Google Scholar
• Hazelton G. A., Klaassen C. D. UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxide. Differences in activation and induction properties in rat and mouse liver. Drug Metab. Disp. 1988; 16: 30–36
   PubMedGoogle Scholar
• Scott W. J., Beliles R. P., Silverman H. I. The comparative acute toxicity of two cardiac glycosides in adult and newborn rats. Toxicol. Appl. Pharmacol. 1971; 20: 599–601
   PubMed Web of Science ®Google Scholar
• Gupta R. S., Chopra A., Stetsko D. K. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). J. Cell Physiol. 1986; 127: 197–206
   PubMed Web of Science ®Google Scholar
• Gill W. B., Schumacher G. F., Bibbo G. F., Straus F. H., Schoen-berg H. W. Association of diethylstilbestrol exposure in utero with cryptor-chidism, testicular hypoplasia and semen abnormalities. J. Urol. 1979; 122: 36–39
   PubMed Web of Science ®Google Scholar
• Barsotti D. A., Abrahamson L. J., Allen L. J. Hormonal alterations in female rhesus monkeys fed a diet containing 2,3,7,8-tetrachlorodibenzo-p-dioxin. Bull. Environ. Contamin. Toxicol. 1979; 21: 63–469
   Google Scholar
• Rier S. E., Martin D. C., Bowman R. E., Dmowski W. P., Becker J. L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 1993; 21: 433–441
   PubMedGoogle Scholar
• Cooper R. L., Kavlock R. J. Endocrine disruptors and reproductive development: A weight-of-evidence overview. J. Endocrinol. 1997; 152: 159–166
   PubMed Web of Science ®Google Scholar
• Mably T. A., Moore R. W., Peterson R. E. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Effects on androgenic status. Toxicol. Appl. Pharmacol. 1992; 114: 97–107
   PubMed Web of Science ®Google Scholar
• Mably T. A., Bjerke D. L., Moore R. W., Gendron-Fitzpatrick A., Peterson R. E. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects on spermatogenesis and reproductive capability. Toxicol. Appl. Pharmacol. 1992; 114: 118–126
   PubMed Web of Science ®Google Scholar
• Gray L. E., Ostby J. S. In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicol. Appl. Pharmacol. 1995; 133: 285–294
   PubMed Web of Science ®Google Scholar
• Shore R. F., Douben P. E. Predicting ecotoxicological impacts of environmental contaminants on terrestrial small mammals. Rev. Environ. Contamin. Toxicol. 1994; 134: 49–89
   PubMedGoogle Scholar
• Babic-Gojmerac T., Kniewald Z., Kniewald J. Testosterone metabolism in neuroendocrine organs in male rats under atrazine and deethylatrazine influence. J. Steroid. Biochem. 1989; 33: 141–146
   PubMedGoogle Scholar
• Jobling S., Reynolds T., White R., Parker M. G., Sumpter J. P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 1995; 103: 582–587
   PubMed Web of Science ®Google Scholar
• Gray L. E.J., Ostby J. M., Marshall R. The fungizide vinclozolin inhibits morphological sex differentiation in the male rat. Biol. Reprod. 1993; 48(Suppl.)97
   Google Scholar
• Kelce W. R., Monosson E., Gamcsik M. P., Laws S. C., Gray L. E. Environmental hormone disruptors: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol. Appl. Pharmacol. 1994; 126: 276–285
   PubMed Web of Science ®Google Scholar
• Kelce W. R., Stone C. R., Laws S. C., Gray L. E., Kemppainen J. A., Wilson E. M. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 1995; 375: 581–585
   PubMed Web of Science ®Google Scholar
• DeVito M. J., Thomas T., Martin E., Umbreit T. H., Gallo M. A. Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Tissue-specific regulation of estrogen receptor in CD1 mice. Toxicol. Appl. Pharmacol. 1992; 113: 284–292
   PubMed Web of Science ®Google Scholar
• Facemire C. F., Gross T. S., Guillette L. J. Reproductive impair ment in the Florida panther: Nature or nurture?. Environ. Health Perspect. 1995; 103(Suppl. 4)79–86
   PubMed Web of Science ®Google Scholar
• DeGuise S., Martineau D., Beland P., Fournier M. Possible mechanisms of action of environmental contaminants on St. Lawrence beluga whales (Delphinapterus leucas). Environ. Health Perspect. 1995; 103(Suppl. 4)73–77
   Google Scholar
• Fry D. M., Toone C. K. DDT-induced feminization of gull embryos. Science 1981; 21(213)922–924
   Google Scholar
• Walker M. K., Cooke P. M., Butterworth B. C., Zabel E. W., Peterson R. E. Potency of a complex mixture of polychlorinated diazo-p-dioxin, dibenzofuran, and biphenyl congeners compared to 2,3,7,8-tetrachlorodibenzo-p-dioxin in causing fish early life stage mortality. Fundam. Appl. Toxicol. 1996; 30(2)178–186
   PubMedGoogle Scholar
• Sukumar A., Karpagaganapathy P. R. Pesticide-induced atresia in ovary of a fresh water fish, Colisa lalia (Hamilton-Buchanan). Bull. Environ. Contamin. Toxicol. 1992; 48: 457–462
   PubMed Web of Science ®Google Scholar
• Wild C. P., Hasegawa R., Barraud L., Chutimataewin L., Chapot B., Nobuyuki I., Montesano R. Aflatoxin–albumin adducts: A basis for comparative carcinogenesis between animals and humans. Cancer Epidemiol. Biomarkers Prev. 1996; 5: 179–189
   PubMed Web of Science ®Google Scholar